Related Experiment Videos
Risk factor screening and intervention: a psychological/behavioral cost or a benefit?
Controlled Clinical Trials
|May 1, 1981
Summary
Screening and intervention in high-risk samples (HRS) showed no psychological costs. The high-risk group experienced fewer depressive symptoms than the low-risk group (LRS) in this clinical trial analysis.
Area of Science:
- Clinical Psychology
- Cardiology
- Psychosomatic Medicine
Background:
- Assessing psychological impact of clinical trial participation is crucial.
- Understanding anxiety and depression in high-risk samples (HRS) with functional heart symptoms is important.
- Previous studies yielded varied psychological outcomes for screening and intervention programs.
Purpose of the Study:
- To evaluate the psychological costs of screening and intervention in HRS.
- To compare depressive symptoms between HRS and low-risk samples (LRS).
- To integrate findings with existing clinical trial research.
Main Methods:
- Assessment of anxiety, depression, and functional heart symptoms.
- Comparison between high-risk samples (HRS) and low-risk samples (LRS) in clinical trials.
- Analysis of psychological reactions to screening and intervention programs.
Main Results:
- Screening and intervention did not impose psychological costs on the HRS.
- The HRS group exhibited fewer depressive symptoms compared to the LRS group.
- Psychological reactions varied based on person-environment interactions within specific populations.
Conclusions:
- Clinical trial screening and intervention are psychologically safe for HRS.
- Participation in trials may reduce depressive symptoms in high-risk individuals.
- Outcomes are influenced by population-specific person-environment interactions.